Volume 5 (2008), Number 3-4, page 151: The authors of this article sent the following note:
Based on our recent study and confirm with previous published paper (Jianping Jin, Timothy Cardozo, Ruth C. Lovering, Stephen J. Elledge, Michele Pagano and J. Wade Harper, GENES & DEVELOPMENT 18: 2573-2580, 2004), we would like to make a knowledgeable correction for our paper published in Cancer Genomics Proteomics [Xiao GG, Zhou BS, Somlo G, Portnow J, Juhasz A, Un F, Chew H, Gandara D and Yen Y: Identification of F-box/LLR-repeated protein 17 as potential useful biomarker for breast cancer therapy. Cancer Genomics Proteomics 5(3-4): 151-160, 2008]. In our original report, we identified F-box/LLR-repeated protein 17 (FBXL17), but assigned this protein as FBXL17/Skp2. At this time, we think that our original report about FBXL17/Skp2 was inappropriate and confusing although FBXL17 and Skp2 are sharing similar sequence (belonging to the same superfamily member, F-box protein family). Therefore, we want to make this correction. The correct protein identified should be FBXL17 instead of FBXL17/Skp2.
Volume 7, Number 3, page 143: Line 7 of introduction should read: subunit is located on chromosome 14 (2). An antibody that
Volume 7, Number 3, page 143: Right column, line 5 should read: and produces a unique spectrum of spontaneous neoplasms,
Volume 7, Number 3, page 144: Left column, line 19 should read: first fresh frozzen at –130°C and cryostat cut for diagnosis. The
Volume 7, Number 3, page 145: Lef column, line 4 should read: large deletions. The SSCP method is relatively simple and of
- Copyright© 2010 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved